Pharmaceutical giant Pfizer Inc. (PFE) announced it had reached a settlement worth $2.15 billion with Teva Pharmaceutical Industries Ltd. (TEVA) and Sun Pharmaceutical Industries Ltd. (SUNP) after almost a decade of trials over Protonix sales in the United States.
Healthcare Health/Fitness
Elan CEO Kelly Martin's job on the line with shareholder vote
Elan CEO Kelly Martin's future employment with the upcoming shareholder vote. (Photo : Reuters)The image is Elan's CEO Kelly Martin. When former Merrill Lynch banker Kelly Martin took over Elan Pharmaceuticals in 2003, it was well known he did not have any drug industry experience.
Rhoen Klinikum warns of future plans with Fresenius
Rhoen-Klinikum that discussiins with Fresenius SE is not precursor to takeover. Rhoen-Klinikum, a cooperation of hospitals and clinics based out of Bad Neustadt an der Saale in Germany, warned that the vote by its shareholders against the takeover of another German hospital operator is not a precursor for another for its previous bidder, Fresenius.
US$2 Billion Risk for Elan If Royalty Pharma Walks Away
Elan is at risk of losing US$2 billion market value once Royalty Pharma walks away with its takeover deal.
ClearLight sells Outsource to HCA subsidiary
ClearLight Partners sold The Outsource Group to Parallon Business Solutions. (Photo : Reuters )Reuters/Ipsos polling reveals a remarkably high level of approval for nearly all the provisions of the act, often in the 80 percent range, despite opposition of respondents to the ClearLight Partners LLC, a private equity firm based in Newport Beach, California, agreed to sell The Outsource Group to a subsidiary to HCA Holdings called Parallon Business Solutions.
Latest News
Actavis and Medicines360 announced partnership to be able to deliver affordable intrauterine device in the US market.
The following bids, mergers, acquisitions and disposals were reported on Tuesday The following bids, mergers, acquisitions and disposals were reported on Tuesday:- Google Inc bought Israeli mapping startup Waze on Tuesday for just over $1 billion, a source familiar with the matter said, acquiring an online real-time mapping service to safeguard its lead in one of the most crucial aspects of smartphone usage.
TVA Medical raised US$5.9 million from Series B financing for minimally invasive technology for End Stage Renal Failure patients.
Accutest Laboratories receives unitranche financing from Bolder Capital through Monroe Capital LLC. (Photo : Reuters)The image is the corporate logo of Accutest Laboratories.
Virtus Health Pty Ltd great IPO start at 7% its premium and brings possible renewed interest on investing at private equity-backed firms.
Prospira PainCare expands its presence in the northeastern United States through the acquisition of the Pain Management Center.
Robert Ramnarine, former Bristol-Myers executive pleaded guilty to the insider trading charges filed against him.
The following bids, mergers, acquisitions and disposals were reported on Monday. The following bids, mergers, acquisitions and disposals were reported on Monday.
Britain's second largest pharmaceutical company, AstraZeneca, plans on buying U.S. based Pearl Therapeutics.
